scispace - formally typeset
K

Karen A. Golemboski

Publications -  4
Citations -  21

Karen A. Golemboski is an academic researcher. The author has contributed to research in topics: Carcinogen & Interferon. The author has an hindex of 3, co-authored 4 publications receiving 20 citations.

Papers
More filters
Journal ArticleDOI

Effect of 7,12-Dimethylbenz[a]anthracene on Production and Action of Gamma Interferon

TL;DR: The data suggest that DMBA treatment can inhibit the production but not the antivirus activity of murine gamma IFN, and DMBA was either added to target cells before the addition of exogenous Gamma IFN or mixed together with exogenous gammaIFN.
Journal ArticleDOI

Kinetics of Inhibition of in vitro Interferon-Alpha/Beta Production after Benzo-(a)-Pyrene Exposure

Karen A. Golemboski, +1 more
- 01 Jan 1985 - 
TL;DR: Data indicated that IFN induction was not completely inhibited by BP treatment, but, rather, the peak of IFN production was delayed, and mouse embryo cultures from SENCAR mice showed the same pattern of delayed IFNProduction when treated with BP.
Journal ArticleDOI

Reversibility of Inhibition of Interferon-alpha/beta Induction by Benzo[a]pyrene

TL;DR: The results suggest that toxicity of carcinogens to cells does not play a major role in inhibition of IFN induction by carcinogens.
Journal ArticleDOI

Genetics of susceptibility of mice to inhibition of interferon induction by benzo-(a)-pyrene.

TL;DR: Embryonic fibroblasts prepared from four different strains of mice suggest parallels between genetically controlled sensitivity to tumor induction byBP and genetically controlled susceptibility to inhibition of IFN induction by BP.